SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

Remembering William A. Anders

June 20, 2024, 7:01AMNuclear News

William A. Anders, former chairman of the Nuclear Regulatory Commission and a former member of the American Nuclear Society, died on June 7 at 90 years of age.In a June 18 statement, the NRC...